Alchemia Limited
Records under this name other than patents Alchemia Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,737,287 | Anomeric derivatives of monosaccharides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,426,345 | Method of drug design Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,709,571 | Method of drug design Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,994,140 | Classes of compounds that interact with GPCRs Formerly held Term ended Term ended Apr 19, 2026 · USPTO record | Term ended | Term ended Apr 19, 2026 | USPTO record |
| US 7,291,623 | Compounds that interact with kinases Formerly held Term ended Term ended Mar 4, 2024 · USPTO record | Term ended | Term ended Mar 4, 2024 | USPTO record |
| US 8,114,970 | Synthetic heparin monosaccharides Formerly held Term ended Term ended Oct 27, 2023 · USPTO record | Term ended | Term ended Oct 27, 2023 | USPTO record |
| US 8,222,381 | Derivatives of monosaccharides for drug discovery Formerly held Term ended Term ended Sep 30, 2023 · USPTO record | Term ended | Term ended Sep 30, 2023 | USPTO record |
| US 8,673,586 | Compounds that interact with kinases Formerly held Term ended Term ended Sep 5, 2023 · USPTO record | Term ended | Term ended Sep 5, 2023 | USPTO record |
| US 7,989,422 | Antibacterial agents Formerly held Lapsed on the fee record Ended Aug 2, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 2, 2023 | USPTO record |
| US 8,093,227 | Monosaccharide compounds and methods therefor Formerly held Term ended Term ended Mar 23, 2023 · USPTO record | Term ended | Term ended Mar 23, 2023 | USPTO record |